Page last updated: 2024-09-04

atrasentan and Impotence

atrasentan has been researched along with Impotence in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Carneiro, FS; Carneiro, ZN; Clinton Webb, R; Ergul, A; Giachini, FR; Leite, R; Lima, VV; Nogueira, EF; Nunes, KP; Rainey, WE; Tostes, RC	1

Other Studies

1 other study(ies) available for atrasentan and Impotence

Article	Year
Activation of the ET-1/ETA pathway contributes to erectile dysfunction associated with mineralocorticoid hypertension. The journal of sexual medicine, 2008, Volume: 5, Issue:12 Topics: Animals; Atrasentan; Blood Pressure; Desoxycorticosterone; Dose-Response Relationship, Drug; Endothelin B Receptor Antagonists; Endothelin-1; Erectile Dysfunction; Gene Expression; Hypertension; In Vitro Techniques; Male; Mitogen-Activated Protein Kinase 3; Muscle, Smooth, Vascular; Penis; Pyrrolidines; Rats; Receptor, Endothelin A; Receptor, Endothelin B; Reverse Transcriptase Polymerase Chain Reaction; rho-Associated Kinases; RNA, Messenger	2008

Article

Year

Activation of the ET-1/ETA pathway contributes to erectile dysfunction associated with mineralocorticoid hypertension.

The journal of sexual medicine, 2008, Volume: 5, Issue:12

Topics: Animals; Atrasentan; Blood Pressure; Desoxycorticosterone; Dose-Response Relationship, Drug; Endothelin B Receptor Antagonists; Endothelin-1; Erectile Dysfunction; Gene Expression; Hypertension; In Vitro Techniques; Male; Mitogen-Activated Protein Kinase 3; Muscle, Smooth, Vascular; Penis; Pyrrolidines; Rats; Receptor, Endothelin A; Receptor, Endothelin B; Reverse Transcriptase Polymerase Chain Reaction; rho-Associated Kinases; RNA, Messenger

2008